Earlier this year, the FDA provided an initial draft for the utilization of human- and animal-derived materials in cell and gene therapy manufacturing. The adoption of animal-origin free components aligns with the industry’s commitment to safety and quality, as they significantly lower the risk of contamination from animal-derived pathogens.  

A new review by Zhang et al (2024) discusses the use of immune cells as carriers for drug delivery systems to cross the blood-brain barrier. This approach shows promise in treating neurodegenerative diseases like Parkinson’s disease by targeting inflamed brain regions and reducing neuroinflammation​.

Ever wondered how to channel your inner mad scientist? This Halloween season, AMSBIO brings you the ultimate guide to create spooky science.

In June 2023, the International Society for Stem Cell Research (ISSCR) released their standards for human stem cell use in research. The overall purpose of these standards is to provide scientists with a set of recommendations in order to meet the minimum characterization and reporting criteria for research laboratories working with human stem cells. We’ve put together a list to highlight some of the key parameters to consider to ensure you meet the new publication guidelines.

Cell Culture Dish article by Ben Smith and Hajime Ohnuki.